Aptus Pharma Financials

BSE: 544529

₹308.05

₹-6.25 (-1.99%)

As on 02-Sep-2026IST

Market cap

₹528 Cr

Revenue (TTM)

₹47 Cr

P/E Ratio

114.4

P/B Ratio

15.7

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Operating Revenue	46.57	24.56	17.86	13.90	--	--
Total Income	46.71	24.64	17.88	13.90	--	--
Total Expenditure	39.12	19.71	16.31	13.28	--	--
EBITDA	7.45	4.85	1.55	0.62	--	--
Depreciation	0.41	0.27	0.21	0.18	--	--
EBIT	7.05	4.58	1.33	0.44	--	--
Interest	0.81	0.47	0.24	0.14	--	--
Other Income	0.13	0.08	0.03	--	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	6.37	4.20	1.12	0.30	--	--
Provision for Tax	1.75	1.10	0.32	0.10	--	--
Profit after Tax	4.62	3.10	0.80	0.19	--	--

Liabilities (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Shareholder's Funds	23.35	6.97	1.77	0.97	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.79	2.80	4.07	2.08	--	--
Current Liabilities	19.31	12.08	4.14	3.13	--	--
Total Liabilities	43.53	21.92	10.03	6.22	--	--

Assets (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Non-Current Assets	8.21	2.11	1.65	0.53	--	--
Current Assets	35.24	19.74	8.32	5.65	--	--
Total Assets	43.53	21.92	10.03	6.22	--	--
Total Debt*	7.18	10.36	5.31	2.21	--	--
Net Current Assets	15.93	7.65	4.19	2.52	--	--
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Cash From Operating Activities	-5.60	-1.84	-2.17	-0.18	--	--
Cash Flow from Investing Activities	-6.37	-0.54	-0.30	-0.35	--	--
Cash from Financing Activities	7.79	6.68	2.86	0.81	--	--
Net Cash Inflow / Outflow	-4.19	4.30	0.38	0.28	--	--

Financials Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Adjusted EPS (₹)	2.69	0.50	2.13	0.52	--	--
Cash EPS (₹)	2.93	0.54	2.70	1.00	--	--
Adjusted Book Value (₹)	13.61	1.11	4.71	2.58	--	--
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	-8.17	-3.68	-72.49	-6.03	--	--
Free Cash Flow per Share (₹)	-13.15	-5.66	-89.97	-22.00	--	--

Profitability Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
ROCE (%)	30.01	38.22	26.47	13.79	--	--
ROE (%)	30.48	70.99	58.36	20.06	--	--
ROA (%)	14.15	19.48	9.88	3.14	--	--
EBIT Margin (%)	15.13	18.67	7.46	3.15	--	--
Net Margin (%)	9.89	12.58	4.46	1.40	--	--
Cash Profit Margin (%)	10.51	13.49	5.64	2.67	--	--

Growth Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Revenue Growth (%)	89.65	37.52	28.49	--	--	--
EBIT Growth (%)	53.71	244.14	203.83	--	--	--
Net Profit Growth (%)	49.05	288.37	310.76	--	--	--
EPS Growth (%)	443.21	-76.70	310.76	--	--	--
Book Value Growth (%)	235.14	294.34	82.41	--	--	--

Valuation Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Price / Earnings	20.74	--	--	--	--	--
Price / Book Value	10.26	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	32.38	2.06	2.99	3.19	--	--
Close Price (₹)	139.66	--	--	--	--	--
High Price (₹)	145.60	--	--	--	--	--
Low Price (₹)	28.00	--	--	--	--	--
Market Cap (₹ Cr)	239.52	--	--	--	--	--

Solvency Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debt to Equity	0.31	1.49	3.00	2.28	--	--
Short term debt to equity ratio	0.28	0.95	0.56	--	--	--
Current Ratio	1.83	1.63	2.01	1.81	--	--
Quick Ratio	1.12	1.05	1.18	1.07	--	--
Interest Coverage	8.92	9.97	5.67	3.06	--	--

Operating Efficiency Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debtors to sales (%)	40.28	22.96	18.78	17.26	--	--
Asset Turnover	1.47	1.57	2.23	2.28	--	--
Receivable days	93.10	65.80	58.41	62.23	--	--
Inventory Days	78.71	76.71	58.13	59.65	--	--
Payable days	80.80	53.78	72.69	104.57	--	--
Cash Conversion Cycle	91.00	88.73	43.86	17.31	--	--